NDC 48433-048-01 - Hydralazine Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 48433-048
- Requested NDC
- 48433-048-01
- Package NDCs from labels
- 48433-048-01, 48433-048-20
- Manufacturer
- Cardinal Health 107, LLC
- Effective date
- 2026-09-14
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Hydralazine Hydrochloride - Cardinal Health 107, LLC | Cardinal Health 107, LLC | 2026-09-14 | HUMAN PRESCRIPTION DRUG LABEL |
| Hydralazine Hydrochloride - Safecor Health, LLC | Safecor Health, LLC | 2026-03-11 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 48433-048-01 | Hydralazine Hydrochloride | 1 in 1 BLISTER PACK | TABLET | 1 | 2 | |
| 48433-048-20 | Hydralazine Hydrochloride | 100 in 1 CARTON | TABLET | 100 | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Coupler LLC | 4aa1b3e8-9389-fe2c-e063-6294a90a7fb9 | 2026-02-12 | Warnings, Adverse reactions | 905225 FD171B778Y |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | REMEDYREPACK INC. | 89afc8ef-27c4-489a-81de-3f8f65f6bbb8 | 2026-02-09 | Warnings, Adverse reactions | 905225 FD171B778Y |
| HydrALAZINE Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Strides Pharma Science Limited | b3d1786d-c3ff-42f1-a09f-37a9c9021e5a | 2026-02-02 | Warnings, Adverse reactions | 905225 905199 905395 905222 FD171B778Y |
| HYDRALAZINE HYDROCHLORIDE | HYDRALAZINE HYDROCHLORIDE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | a04eefaf-ba3c-448d-8ece-4aa9ab2e3508 | 2026-01-09 | Warnings, Adverse reactions | 905225 905199 905395 905222 FD171B778Y |
| HYDRALAZINE HYDROCHLORIDE | HYDRALAZINE HYDROCHLORIDE | PD-Rx Pharmaceuticals, Inc. | e9450e82-329f-4fd8-a0b3-3e8e22715965 | 2026-01-07 | Warnings, Adverse reactions | 905395 FD171B778Y |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Fresenius Kabi USA, LLC | bf1b7c2f-535c-45bb-928a-65606d87685e | 2025-12-16 | Warnings, Adverse reactions | FD171B778Y |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Chartwell RX, LLC | 0c7f9bd0-6c0a-4521-b77a-3582faa96874 | 2025-12-10 | Warnings, Adverse reactions | 905225 905199 905395 905222 FD171B778Y |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | A-S Medication Solutions | 7253aaa0-e272-499f-9bfa-304e9556a8fb | 2025-12-05 | Warnings, Adverse reactions | 905395 FD171B778Y |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | A-S Medication Solutions | f16f1d87-f9e6-4555-9baf-26ff17cb1d28 | 2025-12-05 | Warnings, Adverse reactions | 905225 905395 FD171B778Y |
| BiDil | HYDRALAZINE HYDROCHLORIDE AND ISOSORBIDE DINITRATE | Azurity Pharmaceuticals, Inc. | e1e63cd5-d1e4-4af5-bad5-1ad41ea46b00 | 2025-11-30 | Warnings, Adverse reactions | FD171B778Y |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Fresenius Kabi USA, LLC | f34904dc-c945-4de4-8594-34e4f4ac1983 | 2025-11-28 | Warnings, Adverse reactions | FD171B778Y |
| HYDRALAZINE HYDROCHLORIDE | HYDRALAZINE HYDROCHLORIDE | Eugia US LLC | e08d8b6c-a184-4dd5-84ef-bac90e4b1c33 | 2025-11-11 | Warnings, Adverse reactions | FD171B778Y |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Cardinal Health 107, LLC | 336b11da-e592-4386-921f-3c136d754f2a | 2025-11-06 | Warnings, Adverse reactions | 905225 905395 FD171B778Y |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Coupler LLC | 41c019e3-7b07-5f12-e063-6294a90a5365 | 2025-10-22 | Warnings, Adverse reactions | 905199 FD171B778Y |
| HYDRALAZINE HYDROCHLORIDE | HYDRALAZINE HYDROCHLORIDE | Medical Purchasing Solutions, LLC | 3f8fb1fc-ffef-4f94-e063-6294a90a2b82 | 2025-09-24 | Warnings, Adverse reactions | FD171B778Y |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Mylan Institutional Inc. | 493a8b7e-5bb1-4db2-91a7-77ed87864131 | 2025-07-22 | Warnings, Adverse reactions | ANDA089097 ANDA088467 ANDA088468 905225 905199 905395 FD171B778Y |
| hydrALAZINE Hydrochloride | HYDRALAZINE HYDROCHLORIDE | ProPharma Distribution | 3855c3da-ff25-8301-e063-6294a90a22b3 | 2025-07-18 | Warnings, Adverse reactions | FD171B778Y |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Proficient Rx LP | 024ac6b8-5ce0-4435-9b11-b1806c511d7b | 2025-07-01 | Warnings, Adverse reactions | 905225 FD171B778Y |
| Isosorbide dinitrate and hydralazine hydrochloride | ISOSORBIDE DINITRATE AND HYDRALAZINE HYDROCHLORIDE | Ingenus Pharmaceuticals, LLC | 8f54d5a3-169f-48dd-9250-2c176d2bd9ad | 2025-06-03 | Warnings, Adverse reactions | FD171B778Y |
| Hydralazine Hydrochloride | HYDRALAZINE HYDROCHLORIDE | Henry Schein, Inc. | 4d1f55aa-e924-4540-ae9f-bd7362a82f33 | 2025-05-20 | Warnings, Adverse reactions | FD171B778Y |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.